{"entity":{"type":"insider","cik":"0001874962","url":"/insider/0001874962","json_url":"/insider/0001874962.json","name":"Appelhans Dannielle","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2022-08-12","last":"2023-12-11","span_basis":"filed_date"},"name_variants":[{"name":"Appelhans Dannielle","source":"filing","n_filings":5,"first_seen":"2022-08-12","last_seen":"2023-12-11"}],"transactions":[{"id":8685440,"accession":"0001415889-23-016186","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-016186","line_url":"/filing/0001415889-23-016186","is_derivative":false,"issuer_cik":"0001733294","issuer_name":"Generation Bio Co.","issuer_ticker":"GBIO","issuer_name_source":null,"issuer_url":"/issuer/0001733294","owner_cik":"0001874962","owner_name":"Appelhans Dannielle","owner_display_name":"Appelhans Dannielle","owner_url":"/insider/0001874962","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":1.79238875,"price_display":"1.79","price_state":"stated","total_value":14339.11,"total_display":"14,339.11","total_whole":"14,339","shares_owned_after":7363.0,"shares_owned_after_display":"7,363","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-08","filed_date":"2023-12-11","scope":"insider","n_lines":2},{"id":8201969,"accession":"0001415889-23-015929","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-015929","line_url":"/filing/0001415889-23-015929#line-1","is_derivative":false,"issuer_cik":"0001733294","issuer_name":"Generation Bio Co.","issuer_ticker":"GBIO","issuer_name_source":null,"issuer_url":"/issuer/0001733294","owner_cik":"0001874962","owner_name":"Appelhans Dannielle","owner_display_name":"Appelhans Dannielle","owner_url":"/insider/0001874962","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":18000.0,"total_display":"18,000.00","total_whole":"18,000","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-04","filed_date":"2023-12-06","scope":"insider"},{"id":7965632,"accession":"0001104659-23-026139","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-026139","line_url":"/filing/0001104659-23-026139#line-1","is_derivative":false,"issuer_cik":"0001709401","issuer_name":"Rubius Therapeutics, Inc.","issuer_ticker":"RUBY","issuer_name_source":null,"issuer_url":"/issuer/0001709401","owner_cik":"0001874962","owner_name":"Appelhans Dannielle","owner_display_name":"Appelhans Dannielle","owner_url":"/insider/0001874962","role":"Officer (CEO and President)","role_mark":"O","role_mark_label":"Officer (CEO and President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10385.0,"shares_display":"10,385","price_per_share":0.1274,"price_display":"0.13","price_state":"stated","total_value":1323.049,"total_display":"1,323.05","total_whole":"1,323","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-24","filed_date":"2023-02-27","scope":"insider"},{"id":8586081,"accession":"0001104659-23-009464","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-009464","line_url":"/filing/0001104659-23-009464#line-2","is_derivative":false,"issuer_cik":"0001709401","issuer_name":"Rubius Therapeutics, Inc.","issuer_ticker":"RUBY","issuer_name_source":null,"issuer_url":"/issuer/0001709401","owner_cik":"0001874962","owner_name":"Appelhans Dannielle","owner_display_name":"Appelhans Dannielle","owner_url":"/insider/0001874962","role":"Officer (CEO and President)","role_mark":"O","role_mark_label":"Officer (CEO and President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3878.0,"shares_display":"3,878","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":969.5,"total_display":"969.50","total_whole":"970","shares_owned_after":10385.0,"shares_owned_after_display":"10,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-01","scope":"insider"},{"id":6662211,"accession":"0001709401-22-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001709401-22-000016","line_url":"/filing/0001709401-22-000016#line-2","is_derivative":false,"issuer_cik":"0001709401","issuer_name":"Rubius Therapeutics, Inc.","issuer_ticker":"RUBY","issuer_name_source":null,"issuer_url":"/issuer/0001709401","owner_cik":"0001874962","owner_name":"Appelhans Dannielle","owner_display_name":"Appelhans Dannielle","owner_url":"/insider/0001874962","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5737.0,"shares_display":"5,737","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":4589.6,"total_display":"4,589.60","total_whole":"4,590","shares_owned_after":6763.0,"shares_owned_after_display":"6,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-10","filed_date":"2022-08-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001733294","name":"Generation Bio Co.","url":"/issuer/0001733294","role":"Director","n_filings":2,"first_seen":"2023-12-06","last_seen":"2023-12-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001709401","name":"Rubius Therapeutics, Inc.","url":"/issuer/0001709401","role":"Officer (CEO and President)","n_filings":3,"first_seen":"2022-08-12","last_seen":"2023-02-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001874962","retrieved_at":"2026-08-26T14:34:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}